TGF-β downregulation-induced cancer cell death is finely regulated by the SAPK signaling cascade |
Han, Zhezhu
(Institute for Cancer Research, Yonsei University College of Medicine)
Kang, Dongxu (Institute for Cancer Research, Yonsei University College of Medicine) Joo, Yeonsoo (Institute for Cancer Research, Yonsei University College of Medicine) Lee, Jihyun (Institute for Cancer Research, Yonsei University College of Medicine) Oh, Geun-Hyeok (Institute for Cancer Research, Yonsei University College of Medicine) Choi, Soojin (Institute for Cancer Research, Yonsei University College of Medicine) Ko, Suwan (Institute for Cancer Research, Yonsei University College of Medicine) Je, Suyeon (Institute for Cancer Research, Yonsei University College of Medicine) Choi, Hye Jin (Department of Internal Medicine, Yonsei University College of Medicine) Song, Jae J. (Institute for Cancer Research, Yonsei University College of Medicine) |
1 | Barranco-Medina, S., Lazaro, J. J. & Dietz, K. J. The oligomeric conformation of peroxiredoxins links redox state to function. FEBS Lett. 583, 1809-1816 (2009). DOI |
2 | Ip, Y. T. & Davis, R. J. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol. 10, 205-219 (1998). DOI |
3 | Turjanski, A. G., Vaque, J. P. & Gutkind, J. S. MAP kinases and the control of nuclear events. Oncogene 26, 3240-3253 (2007). DOI |
4 | Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537-549 (2009). DOI |
5 | Guo, Y. L., Baysal, K., Kang, B., Yang, L. J. & Williamson, J. R. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273, 4027-4034 (1998). DOI |
6 | Hartsough, M. T. & Mulder, K. M. Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells. J. Biol. Chem. 270, 7117-7124 (1995). DOI |
7 | Engel,M. E., McDonnell, M. A., Law, B. K. & Moses, H. L. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem. 274, 37413-37420 (1999). DOI |
8 | Begas, P., Liedgens, L., Moseler, A., Meyer, A. J. & Deponte, M. Glutaredoxin catalysis requires two distinct glutathione interaction sites. Nat. Commun. 8, 14835 (2017). DOI |
9 | Friess, H. et al. Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res. 53, 2704-2707 (1993). |
10 | Drabsch, Y. & ten Dijke, P. TGF-beta signalling and its role in cancer progression and metastasis. Cancer Metastas-. Rev. 31, 553-568 (2012). DOI |
11 | Song, J. J. et al. Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2. J. Biol. Chem. 277, 46566-46575 (2002). DOI |
12 | Rhee, S. G., Woo, H. A., Kil, I. S. & Bae, S. H. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J. Biol. Chem. 287, 4403-4410 (2012). DOI |
13 | Kim, J., Kang, D., Sun, B. K., Kim, J. H. & Song, J. J. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex. Cell. Signal. 25, 372-379 (2013). DOI |
14 | Yu, L., Hebert, M. C. & Zhang, Y. E. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J. 21, 3749-3759 (2002). DOI |
15 | Korpal, M. & Kang, Y. Targeting the transforming growth factor-beta signalling pathway in metastatic cancer. Eur. J. Cancer 46, 1232-1240 (2010). DOI |
16 | Kang, D., Park, W., Lee, S., Kim, J. H. & Song, J. J. Crosstalk from survival to necrotic death coexists in DU-145 cells by curcumin treatment. Cell. Signal. 25, 1288-1300 (2013). DOI |
17 | Hanafusa, H. et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J. Biol. Chem. 274, 27161-27167 (1999). DOI |
18 | Yoo, Y. A., Kim, Y. H., Kim, J. S. & Seo, J. H. The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer. Biochim. Biophys. Acta 1783, 438-447 (2008). DOI |
19 | Hernanda, P. Y. et al. SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma. Oncogene 34, 5055-5068 (2015). DOI |
20 | Zhao, Y. et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol. Cancer 16, 79 (2017). DOI |
21 | Roulston, A., Reinhard, C., Amiri, P. & Williams, L. T. Early activation of c-Jun Nterminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J. Biol. Chem. 273, 10232-10239 (1998). DOI |
22 | Zhang, J. et al. ROS and ROS-mediated cellular signaling. Oxid. Med. Cell Longev. 2016, 4350965 (2016). |
23 | Syed, V. TGF-beta signaling in cancer. J. Cell. Biochem. 117, 1279-1287 (2016). DOI |
24 | Mu, Y., Gudey, S. K. & Landstrom, M. Non-Smad signaling pathways. Cell Tissue Res. 347, 11-20 (2012). DOI |
25 | Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94 (1997). DOI |
26 | Chen, Z. et al. ASK1 mediates apoptotic cell death induced by genotoxic stress. Oncogene 18, 173-180 (1999). DOI |
27 | Kim, J. et al. HSP27 modulates survival signaling networks in cells treated with curcumin and TRAIL. Cell. Signal. 24, 1444-1452 (2012). DOI |
28 | Hsieh, C. C. & Papaconstantinou, J. Thioredoxin-ASK1 complex levels regulate ROS-mediated p38 MAPK pathway activity in livers of aged and long-lived Snell dwarf mice. FASEB J. 20, 259-268 (2006). DOI |
29 | Zhang, Y. E. Non-Smad pathways in TGF-beta signaling. Cell Res. 19, 128-139 (2009). DOI |
30 | Matsukawa, J., Matsuzawa, A., Takeda, K. & Ichijo, H. The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 136, 261-265 (2004). DOI |
31 | Tobiume, K. et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222-228 (2001). DOI |
32 | Hayyan, M., Hashim, M. A. & AlNashef, I. M. Superoxide ion: generation and chemical implications. Chem. Rev. 116, 3029-3085 (2016). DOI |
33 | Siegel, P. M. & Massague, J. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3, 807-821 (2003). DOI |
34 | Muller, F. The nature and mechanism of superoxide production by the electron transport chain: Its relevance to aging. J. Am. Aging Assoc. 23, 227-253 (2000). |
35 | Papageorgis, P. TGFbeta signaling in tumor initiation, epithelial-tomesenchymal transition, and metastasis. J. Oncol. 2015, 587193 (2015). |
36 | Massague, J. TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791 (1998). DOI |
37 | Lebrun, J. J. The dual role of TGFbeta in human cancer: from tumor suppression to cancer metastasis. ISRN Mol. Biol. 2012, 381428 (2012). |
38 | Wakefield, L. M. & Hill, C. S. Beyond TGFbeta: roles of other TGFbeta superfamily members in cancer. Nat. Rev. Cancer 13, 328-341 (2013). DOI |
39 | Xu, J., Lamouille, S. & Derynck, R. TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172 (2009). DOI |
40 | Dumont, N. & Arteaga, C. L. Targeting the TGF beta signaling network in human neoplasia. Cancer Cell 3, 531-536 (2003). DOI |
41 | Derynck, R., Akhurst, R. J. & Balmain, A. TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129 (2001). DOI |
42 | Jakowlew, S. B. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev. 25, 435-457 (2006). DOI |
43 | Malhotra, J. D. & Kaufman, R. J. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid. Redox Signal. 9, 2277-2293 (2007). DOI |
44 | Liou, G. Y. & Storz, P. Reactive oxygen species in cancer. Free Radic. Res. 44, 479-496 (2010). DOI |
45 | Burdon, R. H., Gill, V. & Rice-Evans, C. Oxidative stress and tumour cell proliferation. Free Radic. Res. Commun. 11, 65-76 (1990). DOI |
46 | Qu, K. et al. Emodin induces human T cell apoptosis in vitro by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction. Acta Pharmacol. Sin. 34, 1217-1228 (2013). DOI |
47 | Zeeshan, H. M., Lee, G. H., Kim, H. R. & Chae, H. J. Endoplasmic reticulum stress and associated ROS. Int. J. Mol. Sci. 17, 327 (2016). DOI |
48 | Hetz, C., Martinon, F., Rodriguez, D. & Glimcher, L. H. The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha. Physiol. Rev. 91, 1219-1243 (2011). DOI |
49 | Powis, G., Mustacich, D. & Coon, A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29, 312-322 (2000). DOI |
50 | Neuzillet, C. et al. Targeting the TGFbeta pathway for cancer therapy. Pharmacol. Ther. 147, 22-31 (2015). DOI |
51 | Massague, J. TGFbeta signalling in context. Nat. Rev. Mol. Cell Biol. 13, 616-630 (2012). DOI |
52 | Wakefield, L. M. & Roberts, A. B. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29 (2002). DOI |
53 | Massague, J. TGFbeta in cancer. Cell 134, 215-230 (2008). DOI |
54 | Oh, S. et al. Transforming growth factor-beta gene silencing using adenovirus expressing TGF-beta1 or TGF-beta2 shRNA. Cancer Gene. Ther. 20, 94-100 (2013). DOI |
55 | Saitoh, M. et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606 (1998). DOI |
56 | Fujino, G., Noguchi, T., Takeda, K. & Ichijo, H. Thioredoxin and protein kinases in redox signaling. Semin. Cancer Biol. 16, 427-435 (2006). DOI |
57 | Cho, S. G. et al. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276, 12749-12755 (2001). DOI |
58 | Ross, S. & Hill, C. S. How the Smads regulate transcription. Int. J. Biochem. Cell Biol. 40, 383-408 (2008). DOI |
59 | Inman, G. J. Switching TGFbeta from a tumor suppressor to a tumor promoter. Curr. Opin. Genet. Dev. 21, 93-99 (2011). DOI |
60 | Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584 (2003). DOI |
61 | Massague, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783-2810 (2005). DOI |
62 | Jaffe, A. B. & Hall, A. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21, 247-269 (2005). DOI |
63 | Son, Y. et al. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways? J. Signal Transduct. 2011, 792639 (2011). |
64 | Pardali, K. & Moustakas, A. Actions of TGF-beta as tumor suppressor and prometastatic factor in human cancer. Biochim. Biophys. Acta 1775, 21-62 (2007). |
65 | Son, Y., Kim, S., Chung, H. T. & Pae, H. O. Reactive oxygen species in the activation of MAP kinases. Methods Enzymol. 528, 27-48 (2013). |
66 | McCubrey, J. A., Lahair, M. M. & Franklin, R. A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid. Redox Signal. 8, 1775-1789 (2006). DOI |
67 | Zafarullah, M., Li, W. Q., Sylvester, J. & Ahmad, M. Molecular mechanisms of Nacetylcysteine actions. Cell. Mol. Life Sci. 60, 6-20 (2003). DOI |
68 | Huang, F. & Chen, Y. G. Regulation of TGF-beta receptor activity. Cell Biosci. 2, 9 (2012). DOI |
69 | Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L. & Arteaga, C. L. Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810 (2000). DOI |
70 | Shin, I., Bakin, A. V., Rodeck, U., Brunet, A. & Arteaga, C. L. Transforming growth factor beta enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol. Biol. Cell 12, 3328-3339 (2001). DOI |
71 | Wang, S. E. The functional crosstalk between HER2 tyrosine kinase and TGFbeta signaling in breast cancer malignancy. J. Signal Transduct. 2011, 804236 (2011). |
72 | Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270, 2008-2011 (1995). DOI |
73 | Kim, S. I., Kwak, J. H., Wang, L. & Choi, M. E. Protein phosphatase 2A is a negative regulator of transforming growth factor-beta1-induced TAK1 activation in mesangial cells. J. Biol. Chem. 283, 10753-10763 (2008). DOI |
74 | Tuzun, S., Yucel, A. F., Pergel, A., Kemik, A. S. & Kemik, O. Lipid peroxidation and transforming growth factor-beta1 levels in gastric cancer at pathologic stages. Balk. Med. J. 29, 273-276 (2012). |
75 | Santos, C. X., Tanaka, L. Y., Wosniak, J. & Laurindo, F. R. Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 11, 2409-2427 (2009). DOI |
76 | Galan, M. et al. Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. Biochim. Biophys. Acta 1843, 1063-1075 (2014). DOI |
77 | Heldin, C. H., Miyazono, K. & ten Dijke, P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471 (1997). DOI |
78 | Dropmann, A. et al. TGF-beta1 and TGF-beta2 abundance in liver diseases of mice and men. Oncotarget 7, 19499-19518 (2016). |
![]() |